Your browser doesn't support javascript.
loading
Afibrinogenemia caused by a novel homozygous missense mutation, FGB p.Cys241Tyr, in a male patient with recurrent intracranial bleeding: case report and review of literature.
Zdziarska, Joanna; Wypasek, Ewa; Iwaniec, Teresa; Vilar, Rui; Neerman-Arbez, Marguerite; Undas, Anetta.
Affiliation
  • Zdziarska J; Hematology Department, Hematology Clinic, Jagiellonian University Medical College, University Hospital in Krakow, Kraków, Poland.
  • Wypasek E; Faculty of Medicine and Health Sciences, Krakow Specialist Hospital named after John Paul II, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.
  • Iwaniec T; Hematology Department, Hematology Clinic, Jagiellonian University Medical College, University Hospital in Krakow, Kraków, Poland.
  • Vilar R; Department of Genetic Medicine and Development, University Medical School of Geneva, Geneva, Switzerland.
  • Neerman-Arbez M; Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Undas A; Krakow Specialist Hospital named after John Paul II, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
Haemophilia ; 27(1): 26-32, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33245842
ABSTRACT

INTRODUCTION:

Congenital afibrinogenemia is a severe bleeding disorder, sometimes manifesting as thrombosis and/or pregnancy complications. Intracranial haemorrhage (ICH) constitutes the major cause of death in this disease.

METHODS:

We present the case of a male patient with congenital afibrinogenemia, who presented with recurrent intracranial hemorrhages, despite prophylactic fibrinogen substitution. We also review the literature for the risk of intracranial hemorrhages in afibrinogenemia.

RESULT:

Molecular analysis revealed a novel homozygous missense mutation in FGB exon 5, p.Cys241 Tyr, that was named "Fibrinogen Krakow V". DISCUSSION AND

CONCLUSION:

Intracranial hemorrhage is a severe manifestation of afibrinogenemia, also in children. The clinical presentation of afibrinogenemia is variable. Fibrinogen substitution carries a risk of thrombotic complications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Afibrinogenemia Limits: Child / Humans / Male Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Afibrinogenemia Limits: Child / Humans / Male Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Poland